Julio Vera Gonzalez

Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy

T. Harrer, A. Mackensen, D. Mougiakakos, 2022, Blood Advances.

CAR-T Cell Therapy in Patients with Refractory Systemic Autoimmune Diseases Exhibits Less Inflammation, Toxicities and Different Cellular Dynamics Compared to Patients with B Cell Lymphoma

M. Aigner, H. Bruns, Simon Voelkl, 2023, Blood.